If you want to search Cost Curve back issues or link to anything you read here, the web links and archive are online at costcurve.beehiiv.com. You can subscribe there, too.
It’s a late-arriving Curve today because I’m on the road talking to people in the flesh like it’s 2018 or something. They’ve been great meetings, with some interesting reader feedback,
If you want to search Cost Curve back issues or link to anything you read here, the web links and archive are online at costcurve.beehiiv.com. You can subscribe there, too.
I had really hoped that nothing was going to happen over the latter half of last week so that we could all ease into the end-of-year sprint. But it turns
Reminder: The Curve is off the rest of the week (probably), plus Labor Day. Keep a lid on things, pls. Lilly is making its Zepbound obesity med available in vials
If you want to search Cost Curve back issues or link to anything you read here, the web links and archive are online at costcurve.beehiiv.com. You can subscribe there, too.
Sorry for the surprise absence of Cost Curve yesterday. Turns out, there really wasn’t much to say, and I didn’t want to clog your inbox. Speaking of absences, Cost Curve
If you want to search Cost Curve back issues or link to anything you read here, the web links and archive are online at costcurve.beehiiv.com. You can subscribe there, too.
It’s been kind of a wild week, and you’re all probably due for a slightly less verbose Curve today. (It’s not a shorter newsletter, though … but that’s a problem
A quick thank-you to Ian Lopez from Bloomberg Law and Jo Walker from the Evidence Base for including my thoughts in their analyses of the big IRA reveal. It’s clear